In connection with earlier intimation dated May 30, 2022 regarding the Outcome of the Board Meeting for approval of the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2022, and in accordance with Regulation 23 of Listing Regulations, Fermenta Biotech has informed that it enclosed the disclosure of Related Party Transactions for the half year ended March 31, 2022. This information will also be made available at https://www.fermentabiotech.com/investor_relations.php
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: